Publicacións en colaboración con investigadores/as de Centro Nacional de Biotecnología (22)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing

    Clinical Chemistry, Vol. 68, Núm. 5, pp. 668-679

2021

  1. SUMOylation modulates the stability and function of PI3K-p110β

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 8, pp. 4053-4065

2019

  1. Adiponectin accounts for gender differences in hepatocellular carcinoma incidence

    Journal of Experimental Medicine, Vol. 216, Núm. 5, pp. 1108-1119

  2. Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function

    FASEB Journal, Vol. 33, Núm. 1, pp. 643-651

2018

  1. Susceptibility of Zebrafish to Vesicular Stomatitis Virus Infection

    Zebrafish, Vol. 15, Núm. 2, pp. 124-132

2017

  1. Phosphorylable tyrosine residue 162 in the double-stranded RNA-dependent kinase PKR modulates its interaction with SUMO

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Cell senescence is an antiviral defense mechanism

    Scientific Reports, Vol. 6

  2. Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation

    Oncogene, Vol. 35, Núm. 22, pp. 2873-2880

  3. Regulation of Ebola virus VP40 matrix protein by SUMO

    Scientific Reports, Vol. 6

2015

  1. KSHV latent protein LANA2 inhibits sumo2 modification of p53

    Cell Cycle, Vol. 14, Núm. 2, pp. 277-282

  2. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins

    Oncotarget, Vol. 6, Núm. 5, pp. 2992-3002

2013

  1. SUMOylation of p53 mediates interferon activities

    Cell Cycle, Vol. 12, Núm. 17, pp. 2809-2816

2011

  1. SIRT1 stabilizes PML promoting its sumoylation

    Cell Death and Differentiation, Vol. 18, Núm. 1, pp. 72-79

2007

  1. Control of virus infection by tumour suppressors

    Carcinogenesis, Vol. 28, Núm. 6, pp. 1140-1144

  2. Genomic profiling of circulating plasma RNA for the analysis of cancer

    Clinical Chemistry, Vol. 53, Núm. 10, pp. 1860-1863

  3. Novel and unexpected role for the tumor suppressor ARF in viral infection surveillance

    Future Virology, Vol. 2, Núm. 6, pp. 625-629

2005

  1. Resistance to viral infection of super p53 mice

    Oncogene, Vol. 24, Núm. 18, pp. 3059-3062

  2. Tumour biology: Senescence in premalignant tumours

    Nature, Vol. 436, Núm. 7051, pp. 642

2000

  1. Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env

    Vaccine, Vol. 18, Núm. 27, pp. 3123-3133